Yayın:
The paradox of high apolipoprotein A-I levels independently predicting incident type-2 diabetes among Turks

Yükleniyor...
Küçük Resim

Tarih

Kurum Yazarları

Danışman

item.page.editor

Editör

Bölüm / Program

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

ELSEVIER IRELAND LTD

DOI

10.1016/j.ijcard.2008.12.066

Türü

View PlumX Details

Araştırma Projeleri

Akademik Birimler

Dergi Sayısı

Özet

Background: Predictive value of apolipoprotein (apo) A-I for incident hypertension, metabolic syndrome (MetS), type 2 diabetes (DM) and coronary heart disease (CHD) needs further exploration. Methods: A representative sample of Turkish adults was studied with this purpose prospectively. Sex-specific apoA-I tertiles were examined regarding cardiometabolic risk. Results and conclusions: A total of 1044 men and 1067 women (aged 49 +/- 12 years at baseline) were followed up over 7.4 years. High serum apoA-I levels were significantly associated in multivariable analysis with female sex, aging, alcohol intake, (inversely) cigarette smoking and, in women, with systolic blood pressure. Risk of diabetes was predicted in logistic regression in both genders by top versus bottom apoA-I tertile (RR 1.98; [ 95% CI 1.31; 3.0]), additive to age, body mass index (BMI), C-reactive protein (CRP), HDL-cholesterol and lipid lowering drugs. By adding sex hormone-binding globulin to the model in a subset of the sample, the association between high apoA-I and incident diabetes was attenuated only in women. ApoA-I tertiles tended to be positively associated also with hypertension and CHD only in women but this did not reach significance. High compared with low serum apoA-I levels nearly double the risk for incident diabetes, additively to age, BMI, CRP, HDL-cholesterol among Turks. Systemic inflammation concomitant with prevailing MetS might turn apoA-I into proinflammatory particles. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

Tanım

Dergi veya Seri

INTERNATIONAL JOURNAL OF CARDIOLOGY

ISSN

0167-5273

ISBN

Alıntı

Koleksiyonlar

Onay

Gözden geçir

Tamamlayıcı Bilgiler

Referans Gösteren

Related Patent

Related Goal

0

Views

0

Downloads